To ask the Scottish Executive, further to the answer to question S2W-31920 by Mr Andy Kerr on 27 February 2007, whether, following the approval of LucentisĀ® (ranibizumab) on 22 January 2007 by the European Medicines Evaluation Agency, the Scottish Medicines Consortium has made a recommendation regarding the use of t...